Clinical trial
Effects of GLP-1 Receptor Agonists Combined With Healthy Lifestyle Education Prior to Fertility Treatment on Reproductive Outcomes in Obese Women With Polycystic Ovary Syndrome
NCT07687667 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of GLP-1 Receptor Agonists Combined With Healthy Lifestyle Education Prior to Fertility Treatment on Reproductive Outcomes in Obese Women With Polycystic Ovary Syndrome
- Lead sponsor
- Peking University Third Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- December 31, 2029
- Enrollment
- 406 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infertility, female, obesity, polycystic ovary syndrome (pcos)